Cargando…

Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society

Research focused on Down syndrome continued to gain momentum in the last several years and is advancing our understanding of how trisomy 21 (T21) modifies molecular and cellular processes. The Trisomy 21 Research Society (T21RS) is the premier scientific organization for researchers and clinicians s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamlett, Eric D., Flores-Aguilar, Lisi, Handen, Benjamin, Potier, Marie-Claude, Granholm, Ann-Charlotte, Sherman, Stephanie, Puig, Maria Victoria, Santoro, Jonathan D., Carmona-Iragui, María, Rebillat, Anne-Sophie, Head, Elizabeth, Strydom, André, Busciglio, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090974/ https://www.ncbi.nlm.nih.gov/pubmed/37064334 http://dx.doi.org/10.1159/000526021

Ejemplares similares

Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey
por: Hüls, Anke, et al.
Publicado: (2021)

DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients
por: Moreau, Manon, et al.
Publicado: (2022)

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey
por: Emes, David, et al.
Publicado: (2021)

Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome
por: Real de Asua, Diego, et al.
Publicado: (2021)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
por: Baumer, Nicole T., et al.
Publicado: (2022)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey
por: Pinku, Halder, et al.
Publicado: (2022)

Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
por: Ledreux, Aurélie, et al.
Publicado: (2021)

Oxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and Dementia
por: Coskun, Pinar E., et al.
Publicado: (2012)

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
por: Lemoine, L., et al.
Publicado: (2020)

Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

A Role for Thrombospondin-1 Deficits in Astrocyte-Mediated Spine and Synaptic Pathology in Down's Syndrome
por: Garcia, Octavio, et al.
Publicado: (2010)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated
por: Hüls, Anke, et al.
Publicado: (2022)

A New Role for RNA G-quadruplexes in Aging and Alzheimer’s Disease
por: Kallweit, Lena, et al.
Publicado: (2023)

On the origin of trisomy 21 Down syndrome
por: Hultén, Maj A, et al.
Publicado: (2008)

Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome
por: Botté, Alexandra, et al.
Publicado: (2020)

Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
por: García, Octavio, et al.
Publicado: (2022)

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

On the paternal origin of trisomy 21 Down syndrome
por: Hultén, Maj A, et al.
Publicado: (2010)

Postmortem Neocortical (3)H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease
por: Pivtoraiko, Violetta N., et al.
Publicado: (2021)

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study
por: Pentz, Rowan, et al.
Publicado: (2020)

Evaluation of biochemical and hematological parameters in adults with Down syndrome
por: de Gonzalo-Calvo, David, et al.
Publicado: (2020)

Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome
por: Kamer, Angela R., et al.
Publicado: (2016)

Mechanisms Involved in Epileptogenesis in Alzheimer’s Disease and Their Therapeutic Implications
por: Altuna, Miren, et al.
Publicado: (2022)

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome
por: Dekker, Alain D., et al.
Publicado: (2018)

Aging in Down Syndrome: Latest Clinical Advances and Prospects
por: Martini, Alessandra C., et al.
Publicado: (2021)

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease
por: Dekker, Alain D., et al.
Publicado: (2017)

Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)

Age-Related Neurodegeneration and Memory Loss in Down Syndrome
por: Lockrow, Jason P., et al.
Publicado: (2012)

Suppressing Aneuploidy-Associated Phenotypes Improves the Fitness of Trisomy 21 Cells
por: Hwang, Sunyoung, et al.
Publicado: (2019)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Acute Regression in Young People with Down Syndrome
por: Mircher, Clotilde, et al.
Publicado: (2017)

Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome
por: Iulita, Maria Florencia, et al.
Publicado: (2022)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Will registries slow down or accelerate innovation?
por: Carr, Andrew
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0bb91rt20vcacvbt63016e6o0a